Background/Aims: Only a small percentage of pathological gamblers utilizes professional treatment for gambling problems. Little is known about which social and gambling-related factors are associated with treatment utilization. The aim of this study was to look for factors associated with treatment utilization for pathological gambling. Methods: The study followed a sampling design with 3 different recruitment channels, namely (1) a general population-based telephone sample, (2) a gambling location sample and (3) a project telephone hotline. Pathological gambling was diagnosed in a telephone interview. Participants with pathological gambling (n = 395) received an in-depth clinical interview concerning treatment utilization, comorbid psychiatric disorders and social characteristics. Results: Variables associated with treatment were higher age [odds ratio (OR) 1.05, 95% confidence interval (CI) 1.03-1.08], an increased number of DSM-IV criteria for pathological gambling (OR 1.34, 95% CI 1.06-1.70), more adverse consequences from gambling (OR 1.10, 95% CI 1.03-1.16) and more social pressure from significant others (OR 1.17, 95% CI 1.07-1.27). Affective disorders were associated with treatment utilization in the univariate analysis (OR 1.81, 95% CI 1.19-2.73), but multivariate analysis showed that comorbid psychiatric disorders were not independently associated. Conclusion: These results indicate that individuals with more severe gambling problems utilize treatment at an older age when more adverse consequences have occurred. Further research should focus on proactive early interventions.

1.
Lorains FK, Cowlishaw S, Thomas SA: Prevalence of comorbid disorders in problem and pathological gambling: systematic review and meta-analysis of population surveys. Addiction 2011;106:490-498.
2.
Slutske WS: Natural recovery and treatment-seeking in pathological gambling: results of two U.S. national surveys. Am J Psychiatry 2006;163:297-302.
3.
Slutske WS, Blaszczynski A, Martin NG: Sex differences in the rates of recovery, treatment-seeking, and natural recovery in pathological gambling: results from an Australian community-based twin survey. Twin Res Hum Genet 2009;12:425-432.
4.
Suurvali H, Hodgins D, Toneatto T, Cunningham J: Treatment seeking among Ontario problem gamblers: results of a population survey. Psychiatr Serv 2008;59:1343-1346.
5.
Finney W, Moos R: Entering treatment for alcohol abuse: a stress and coping model. Addiction 1995;90:1223-1240.
6.
Pulford J, Bellringer M, Abbott M, Clarke D, Hodgins D, Williams J: Reasons for seeking help for a gambling problem: the experiences of gamblers who have sought specialist assistance and the perceptions of those who have not. J Gambl Stud 2009;25:19-32.
7.
Suurvali H, Hodgins DC, Toneatto T, Cunningham JA: Motivators for seeking gambling-related treatment among Ontario problem gamblers. J Gambl Stud 2012;28:273-296.
8.
Premper V, Schulz W: Komorbidität bei pathologischem Glücksspiel. Sucht 2008;54:131-140.
9.
Braun B, Ludwig M, Kraus L, Kroher M, Bühringer G: Ambulante Suchthilfe für pathologische Glücksspieler in Bayern: Passung zwischen Behandlungsbedarf und -angebot. Suchttherapie 2013;14:37-45.
10.
Bischof A, Meyer C, Bischof G, Kastirke N, John U, Rumpf HJ: Comorbid axis I-disorders among subjects with pathological, problem, or at-risk gambling recruited from the general population in Germany: results of the PAGE study. Psychiatry Res 2013;210:1065-1070.
11.
Rumpf HJ, John U, Bischof A, Kastirke N, Bischof G, Meyer C: Pathologisches Glücksspielen und Epidemiologie: die PAGE-Studie; in Buth S, Kalke J, Reimer J (eds): Glücksspielsuchtforschung in Deutschland: Wissenschaftliche Erkenntnisse für Prävention, Hilfe, Politik. Freiburg, Lambertus, 2013, pp 17-27.
12.
American Psychiatric Association (ed): Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, International Version. Washington, American Psychiatric Association, 1995.
13.
World Health Organization: The World Mental Health Survey Initiative. Computer Assisted Personal Interview (CAPI v21.1.1): Gambling Section. Geneva, World Health Organization, 2009.
14.
Kessler RC, Hwang I, LaBrie R, Petukhova M, Sampson NA, Winters KC, Shaffer HJ: DSM-IV pathological gambling in the National Comorbidity Survey Replication. Psychol Med 2008;38:1351-1360.
15.
Rumpf H-J, Meyer C, Hapke U, Bischof G, John U: Inanspruchnahme suchtspezifischer Hilfen von Alkoholabhängigen und -missbrauchern: Ergebnisse der TACOS Bevölkerungsstudie (Utilization of professional help of individuals with alcohol dependence or abuse: findings from the TACOS population study). Sucht 2000;46:9-17.
16.
Wittchen H-U, Beloch E, Garczynski E, Holly A, Lachner G, Perkonigg A, Vodermaier A, Vossen A, Wunderlich U, Zieglgänsberger S: Münchener Composite International Diagnostic Interview (M-CIDI), Version 2.2. München, Max-Planck-Institut für Psychiatrie, 1995.
17.
Fydrich T, Renneberg B, Schmitz B, Wittchen HU: SKID-II. Strukturiertes klinisches Interview für DSM-IV, Achse II: Persönlichkeitsstörungen. Interviewheft. Göttingen, Hogrefe, 1997.
18.
Bischof G, Rumpf HJ, Hapke U, Meyer C, John U: Skala zur Erfassung sozialen Drucks (SSD) (Social Pressure Scale, German version); in Glöckner-Rist A, Rist F, Küfner H (eds): Elektronisches Handbuch zu Erhebungsinstrumenten im Suchtbereich (EHES) (Electronic Handbook on Assessment Instruments in the Addiction Field]. Mannheim, Zentrum für Umfragen, Methoden und Analysen, 2003, vol 3.00. http//www.psy.uni-muenster.de/institut1/ehes/startseite.htm.
19.
Hasin DS: Treatment/self-help for alcohol-related problems: relationship to social pressure and alcohol dependence. J Stud Alcohol 1994;55:660-666.
20.
Vaux A, Phillips J, Holly L, Thomson B, Williams D, Stewart D: The Social Support Appraisal (SS-A) Scale: studies of reliability and validity. Am J Community Psychol 1986;14:195-219.
21.
Moos RH, Cronkite RC, Billings AG, Finney JW: Health and Daily Living Form Manual. Stanford, Stanford University Medical Centers, 1985.
22.
Ledgerwood DM, Arfken CL, Wiedemann A, Bates KE, Holmes D, Jones L: Who goes to treatment? Predictors of treatment initiation among gambling help-line callers. Am J Addict 2013;22:33-38.
23.
Weinstock J, Burton S, Rash CJ, Moran S, Biller W, Krudelbach N, Phoenix N, Morasco BJ: Predictors of engaging in problem gambling treatment: data from the West Virginia problem gamblers help network. Psychol Addict Behav 2011;25:372-379.
24.
Petry NM, Weinstock J, Ledgerwood DM, Morasco BJ: A randomized trial of brief interventions for problem and pathological gambling. J Consult Clin Psychol 2008;76:318-328.
25.
Petry NM, Weinstock J, Morasco BJ, Ledgerwood DM: Brief motivational interventions for college student problem gamblers. Addiction 2009;104:1569-1578.
26.
Larimer ME, Neighbors C, Lostutter TW, Whiteside U, Cronce JM, Kaysen D, Walker DD: Brief motivational feedback and cognitive behavioral interventions for prevention of disordered gambling: a randomized clinical trial. Addiction 2011;107:1148-1158.
27.
Hodgins DC, Currie S, El-Guebaly N, Peden N: Brief motivational treatment for problem gambling: a 24-month follow-up. Psychol Addict Behav 2004;18:293-296.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.